Catalyst Wire Dossier Catalyst Wire Dossier

Peginterferon beta-1a

peginterferon beta-1a · Biogen
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Peginterferon beta-1a, covering 2014-06-13 to 2023-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants [Phase 3]

See pricing